SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Kaplan FS 2005 Fibrodysplasia ossificans progressiva: An historical perspective. Clin Rev Bone Miner Metab 3: 179181.
  • 2
    Kaplan FS, Shore EM, Connor JM 2002 Fibrodysplasia ossificans progressiva (FOP). RoyceP, SteinmannB (eds.) Connective Tissue and Its Heritable Disorders, 2nd ed. Wiley-Liss, New York, NY, USA, 827840.
  • 3
    Kaplan FS, Glaser DL, Shore EM, Deirmengian GK, Gupta R, Delai P, Morhart R, Smith R, Le Merrer M, Rogers JG, Connor MJ, Kitterman JA 2005 The phenotype of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 3: 183188.
  • 4
    Shafritz AB, Shore EM, Gannon FH, Zasloff MA, Taub R, Muenke M, Kaplan FS 1996 Over-expression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med 335: 555561.
  • 5
    Ahn J, de Serrano la Peña L, Shore EM, Kaplan FS 2003 Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis. J Bone Joint Surg Am 85: 667674.
  • 6
    Serrano de la Peña L, Billings PC, Fiori JL, Ahn J, Kaplan FS, Shore EM 2005 Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA. J Bone Miner Res 20: 11681176.
  • 7
    Fiori JL, Billings PC, Serrano de la Peña L, Kaplan FS, Shore EM 2006 Dysregulation of the BMP-p38 MAPK signaling pathway in fibrodysplasia ossificans progressiva (FOP) patients. J Bone Miner Res 21: 902909.
  • 8
    Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho T-J, Choi IH, Connor JM, Delai P, Glaser DL, LeMerrer M, Morhart R, Rogers JG, Smith R, Triffitt JT, Urtizberea JA, Zasloff M, Brown MA, Kaplan FS 2006 A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38: 525527.
  • 9
    Zhang D, Schwarz EM, Rosier RN, Zuscik MJ, Puzas JE, O'Keefe RJ 2003 ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development. J Bone Miner Res 18: 15931604.
  • 10
    Groppe J, Shore EM, Kaplan FS 2007 Functional modeling of the ACVR1 (R206H) mutation in FOP. Clin Orthop 462: 8792.
  • 11
    Gronthos S, Mankani M, Brahim J, Robey PG, Shi S 2000 Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA 97: 1362513630.
  • 12
    Miura M, Gronthos S, Zhao M, Lu B, Fisher LW, Robey PG, Shi S 2003 SHED: Stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci USA 100: 58075812.
  • 13
    Laino G, d'Aquino R, Graziano A, Lanza V, Carinci F, Naro F, Pirozzi G, Papaccio G 2005 A new population of human adult dental pulp stem cells: A useful source of living autologous fibrous bone tissue (LAB). J Bone Miner Res 20: 13941402.
  • 14
    Laino G, Graziano A, d'Aquino R, Pirozzi G, Lanza V, Valiante S, De Rosa A, Naro F, Vivarelli E, Papaccio G 2006 An approachable human adult stem cell source for hard-tissue engineering. J Cell Physiol 206: 693701.
  • 15
    Van Belle H 1972 Kinetics and inhibition of alkaline phosphatases from canine tissues. Biochim Biophys Acta 289: 158168.
  • 16
    Bi Y, Stuelten CH, Kilts T, Wadhwa S, Iozzo RI, Robey PG, Chen XD, Young MF 2005 Extracellular matrix proteoglycans control the fate of bone marrow stromal cells. J Biol Chem 280: 3048130489.
  • 17
    Brugger SM, Merrill AE, Torres-Vazquez J, Wu N, Ting MC, Cho JY, Dobias SL, Yi SE, Lyons K, Bell JR, Arora K, Warrior R, Maxson R 2004 A phylogenetically conserved cis-regulatory module in the Msx2 promoter is sufficient for BMP-dependent transcription in murine and Drosophila embryos. Development 131: 51535165.
  • 18
    Canalis E, Economides AN, Gazzerro E 2003 Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24: 218235.
  • 19
    Shi Y, Massagué J 2003 Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113: 685700.
  • 20
    Sapkota G, Alarcon C, Spagnoli FM, Brivanlou AH, Massague J 2007 Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell 25: 441454.
  • 21
    Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL 2003 Distinct endocytic pathways regulate TGF-β receptor signalling and turnover. Nature Cell Biol 5: 410421.
  • 22
    Hartung A, Bitton-Worms K, Rechtman MM, Wenzel V, Borgermann JH, Hassel S, Henis YI, Knaus P 2006 Different routes of BMP receptor endocytosis influence BMP signaling. Mol Cell Biol 26: 77917805.
  • 23
    Larkin JM, Donzell WC, Anderson RGW 1986 Potassium-dependent assembly of coated pits: New coated pits form as planar clathrin lattices. J Cell Biol 103: 26192627.
  • 24
    Hao Q, Hong SH, Maret W 2007 Lipid raft-dependent endocytosis of metallothionein in HepG2 cells. J Cell Physiol 210: 428435.
  • 25
    Kaplan FS, Glaser DL, Shore EM, Pignolo RJ, Xu M, Zhang Y, Senitzer D, Forman SJ, Emerson SG 2007 Hematopoietic stem-cell contribution to ectopic skeletogenesis. J Bone Joint Surg Am 89: 347357.
  • 26
    Jeffery TK, Upton PD, Trembath RC, Morrell NW 2004 BMP4 inhibits proliferation and promotes myocyte differentiation of lung fibroblasts via Smad1 and JNK pathways. Am J Physiol Lung Cell Mol Physiol 288: L370L378.
  • 27
    Yang X, Long L, Southwood M, Rudarakanchana N, Upton PD, Jeffery TK, Atkinson C, Chen H, Trembath RC, Morrell NW 2005 Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension. Circ Res 96: 10531063.
  • 28
    Lian JB, Stein GS, Javed A, van Wijnen AJ, Stein JL, Montecino M, Hassan MQ, Gaur T, Lengner CJ, Young DW 2006 Networks and hubs for the transcriptional control of osteoblastogenesis. Rev Endocr Metab Disord 7: 116.
  • 29
    Sottile V, Thomson A, Mcwhir J 2003 In vitro osteogenic differentiation of human ES cells. Cloning Stem Cells 5: 149155.